In this highly radiosensitive model, control of the irradiated tumor and CD8+ tumor-infiltrating lymphocytes (TILs) did not differ between the RT/IL-2c combination and RT monotherapy groups, and the control of unirradiated tumors did not differ between the RT/IL-2c combination and IL-2c monotherapy groups [28]. This evidence concerns the gene CD8A and neoplasm.